Literature DB >> 1829930

Combined goserelin and tamoxifen in premenopausal advanced breast cancer: duration of response and survival.

A R Dixon, L Jackson, J F Robertson, R I Nicholson, R W Blamey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829930     DOI： 10.1016/0277-5379(91)90197-l

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.

Authors:  L B Michaud; A U Buzdar
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

2.  Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.

Authors:  R Buzzoni; L Biganzoli; E Bajetta; L Celio; A Fornasiero; L Mariani; N Zilembo; M Di Bartolomeo; A Di Leo; G Arcangeli
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

3.  Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

Authors:  D P Forward; K L Cheung; L Jackson; J F R Robertson
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.